系统地研究双目标导向干
Vittorio Lembo1,2, Giovanni Bottegoni1,3
1Department of Biomolecular Sciences, Università degli Studi di Urbino Carlo Bo, Piazza Rinascimento 6, 61029 Urbino, Italy.
Journal of medicinal chemistry
|June 6, 2024
概括
多目标导向配体 (MTDLs) 通过向多种蛋白质,提供了更好的治疗潜力. 这项研究分析了双目标导向配体 (DTDLS),揭示了现有的疾病病理学和化学结构知识推动了它们的设计,并为创新提供了显著的空间.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 多目标导向配体 (MTDLs) 旨在与多个生物点相互作用,旨在提高治疗疗效和减少副作用.
- 在过去的二十年中,MTDL领域取得了重大进展,探索了新的目标组合和复杂的药物化学方法.
研究的目的:
- 通过文献挖掘,策划一个双目标导向连接体 (DTDLS) 的数据集.
- 分析在DTDL中选择目标的基本理由.
- 评估DTDL在特定目标组合中的化学新性和潜力.
主要方法:
- 文献挖掘以识别和编制DTDL的数据集.
- 对DTDL目标的生物信息和化学基因组分析,包括生物功能,疾病关联和结构性质.
- 对DTDL和单标化合物的比较分析.
主要成果:
- DTDL设计经常依赖于目标病理和现有化学支架之间的既定关联.
- 分析显示,在DTDL开发中经常被利用的绑定口袋中存在相似之处.
- 与单标化合物进行比较,突出了DTDL标选择的具体趋势.
结论:
- 目前的DTDL开发在很大程度上利用了关于疾病机制和化学结构的现有知识.
- 通过合理的多药理学设计新的MTDL存在大量未开发的潜力.
- 该研究提供了对当前环境和MTDL研究的未来方向的见解.
更多相关视频
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
7.8K
10:16Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
Published on: March 12, 2019
44.2K
相关概念视频
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
